Advertisement

Topics

Astellas Pharma US,Inc Company Profile

13:30 EDT 18th June 2018 | BioPortfolio

Launched in April 2005, Astellas was formed by the historical merger of Japan's third and fifth largest pharmaceutical companies - Yamanouchi, founded in 1923, and Fujisawa, founded in 1894.Both companies possessed similarities where it matters most- philosophy and vision. But the companies also differed where it matters most - areas of therapeutic concentration and expertise.
Yamanouchi brought a record of developing blockbuster drugs, a pipeline full of promising new compounds like Fujisawa, a sales and marketing culture of deeply grounded, data-driven expertise.
Fujisawa brought dominance in transplantation, a soaring reputation for in-depth understanding of the disease states and treatments within its market niches, and a track record for developing high-profile, market-leading products that become new standards of care.
With an unrelenting commitment to R&D as a value-creating core of its business, Astellas is consolidated around complementary strengths from Yamanouchi and Fujisawa. Astellas stands on a much stronger, more advanced business platform than either of the former companies could have mounted individually.

Location

3 Parkway North
Deerfield
Illinois
60015
United States of America

Contact

Phone: 800.695.4321
Email: Astellasreimbursement@quorumconsulting.com


News Articles [874 Associated News Articles listed on BioPortfolio]

Astellas Makes Leadership Changes in Canada and U.S.

Sabus appointed GM of Astellas Pharma Canada; Gerber and O'Keefe promoted to new roles in U.S. sales organization Steve Sabus has been named general manager of Astellas Pharma Canada , effective A...

Astellas Pharma concludes $225m Mitobridge acquisition

Japanese company Astellas Pharma has concluded the acquisition of 100% equity in US-based biotechnology firm Mitobridge for a total of...Read More... The post Astellas Pharma concludes $225m Mitobridg...

Astellas exec to join Alkermes

The head of Japanese pharma major Astellas’ (TYO: 4503) US operations is moving to take up a top position…

BRIEF—Astellas appoints Kenji Yasukawa as president and CEO

Japanese drug major Astellas Pharma (TYO: 4503) has announced that its board of directors approved a…

Astellas upgrades Universal Cells licensing deal to a buy

Japanese pharma major Astellas is to pay up to $102.5 million in upfront and milestone payments to acquire…

Astellas Pharma acquires Universal Cells for $102m

Astellas Pharma has acquired Universal Cells for $102.5m in a move to utilize the latter’s technology to produce pluripotent stem cells that have the potential to lower immunological rejection in va...

BRIEF—Astellas to pursue Asian filings for novel second-line RA therapy

Japan’s Astellas Pharma says two Phase III trials - RAJ3 and RAJ4 - of ASP015K (peficitinib hydrobromide)…

FDA priority review status granted to Astellas' AML drug

Astellas Pharma's gilteritinib, which is being developed as a treatment for adult patients with relapsed/refractory FLT3-posi -More- 

Drugs and Medications [250 Associated Drugs and Medications listed on BioPortfolio]

Vesicare [Astellas Pharma Technologies, Inc.]

These highlights do not include all the information needed to use VESIcare safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. ...

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

Moving pharma contracting into the era of accountability.

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Rejuvenating the Face: An Analysis of 100 Absorbable Suture Suspension Patients.

Absorbable suture suspension (Silhouette InstaLift, Sinclair Pharma, Irvine, CA) is a novel, minimally invasive system that utilizes a specially manufactured synthetic suture to help address the issue...

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

A totally new system is needed for drug research and development.

In response to my paper, where I call for abolishment of patents and for drug research and development as a public enterprise, Raj asserts that there is an increase in novel drug discoveries. The fact...

Clinical Trials [84 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 5 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 1 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

The purpose of the study is to provide access to continued treatment for subjects who participated in other Astellas sponsored ASP2215 trials and for whom the Investigator feels the subjec...

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 1 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Companies [758 Associated Companies listed on BioPortfolio]

Astellas Pharma Canada, Inc.

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...

Astellas Pharma Global Development

Astellas Pharma Global Development, located in Deerfield, Illinois, is a group company of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of peo...

Astellas Pharma Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals...

Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...

Potenza Therapeutics, Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and rel...

More Information about "Astellas Pharma US,Inc" on BioPortfolio

We have published hundreds of Astellas Pharma US,Inc news stories on BioPortfolio along with dozens of Astellas Pharma US,Inc Clinical Trials and PubMed Articles about Astellas Pharma US,Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Astellas Pharma US,Inc Companies in our database. You can also find out about relevant Astellas Pharma US,Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...


Corporate Database Quicklinks



Searches Linking to this Company Record